1. Home
  2. ACTU vs ACU Comparison

ACTU vs ACU Comparison

Compare ACTU & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • ACU
  • Stock Information
  • Founded
  • ACTU 2015
  • ACU 1867
  • Country
  • ACTU United States
  • ACU United States
  • Employees
  • ACTU N/A
  • ACU N/A
  • Industry
  • ACTU
  • ACU Industrial Machinery/Components
  • Sector
  • ACTU
  • ACU Consumer Discretionary
  • Exchange
  • ACTU NYSE
  • ACU Nasdaq
  • Market Cap
  • ACTU 135.0M
  • ACU 146.7M
  • IPO Year
  • ACTU 2024
  • ACU N/A
  • Fundamental
  • Price
  • ACTU $8.00
  • ACU $41.38
  • Analyst Decision
  • ACTU Strong Buy
  • ACU
  • Analyst Count
  • ACTU 1
  • ACU 0
  • Target Price
  • ACTU $20.00
  • ACU N/A
  • AVG Volume (30 Days)
  • ACTU 42.0K
  • ACU 14.7K
  • Earning Date
  • ACTU 05-21-2025
  • ACU 04-17-2025
  • Dividend Yield
  • ACTU N/A
  • ACU 1.46%
  • EPS Growth
  • ACTU N/A
  • ACU N/A
  • EPS
  • ACTU N/A
  • ACU 2.48
  • Revenue
  • ACTU N/A
  • ACU $195,491,991.00
  • Revenue This Year
  • ACTU N/A
  • ACU $4.87
  • Revenue Next Year
  • ACTU N/A
  • ACU $3.65
  • P/E Ratio
  • ACTU N/A
  • ACU $16.70
  • Revenue Growth
  • ACTU N/A
  • ACU 2.56
  • 52 Week Low
  • ACTU $5.51
  • ACU $32.85
  • 52 Week High
  • ACTU $11.73
  • ACU $50.00
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • ACU 58.71
  • Support Level
  • ACTU N/A
  • ACU $37.64
  • Resistance Level
  • ACTU N/A
  • ACU $40.99
  • Average True Range (ATR)
  • ACTU 0.00
  • ACU 1.96
  • MACD
  • ACTU 0.00
  • ACU 0.15
  • Stochastic Oscillator
  • ACTU 0.00
  • ACU 89.40

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

Share on Social Networks: